Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and obesity. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
In Indonesia, Novo Nordisk has been driving change in diabetes for over two decades, working closely with stakeholders to address this growing challenge. Building upon our strong heritage in diabetes, we developed a core focus on obesity.